ACTIVE

PHARMACIE TILMAN

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result132,6 k €+32,1 %over 1 year

Gross margin832,3 k €-11,2 %over 1 year

Equity392 k €-24,9 %over 1 year

Workforce7,3 ETP-20,7 %over 1 year

Identity

Source · BCE/KBO

PHARMACIE TILMAN is a Public limited company incorporated in 1996. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Durbuy. It employs on average 7,3 ETP workers (FTE).

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0458.496.432
Incorporation: 15/07/1996
Legal form: Public limited company
Registered office: Rue de Fleurie 1
6941 Durbuy · WallonieSee on map
Contributed capital: 61 973,38 €
Latest accounts: 31/12/2025
Average workforce: 7,3 ETP

Activities (NACE)

47730Dispensing chemist in specialised stores· main 47730Dispensing chemist in specialised stores 52310Warehousing and support activities for transportation 47742Retail sale of medical and orthopaedic goods in specialised stores 47782Other retail sale of new goods in specialised stores 52485Warehousing and support activities for transportation

Joint committees (1)

Signals

ProfitablePositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 20 filings

Trend over 19 financial years

	2025		2024		2023		2022		2021
Income statement
Gross margin	832,3 k €	-11.2%	937,7 k €	+9.9%	853,6 k €	+10.9%	769,7 k €	+7.1%	718,4 k €
EBITDA	344,3 k €	+12.6%	305,6 k €	+18.7%	257,4 k €	+25.5%	205,1 k €	+3.8%	197,6 k €
Operating result	214,8 k €	+26.0%	170,4 k €	+59.9%	106,6 k €	+98.4%	53,7 k €	-3.6%	55,7 k €
Net result	132,6 k €	+32.1%	100,3 k €	+96.5%	51,1 k €	+753%	6 k €	-44.6%	10,8 k €
Balance sheet
Equity	392 k €	-24.9%	521,9 k €	+0.1%	521,6 k €	+0.2%	520,5 k €	+1.2%	514,5 k €
Total assets	2,5 M €	+6.7%	2,4 M €	-1.3%	2,4 M €	-2.3%	2,5 M €	+1.8%	2,4 M €
Cash	136,1 k €	+13.5%	119,9 k €	+78.4%	67,2 k €	-24.2%	88,7 k €	-1.7%	90,2 k €
Debts	2,1 M €	+15.6%	1,8 M €	-1.2%	1,9 M €	-3.4%	1,9 M €	+2.0%	1,9 M €
Other
Workforce	7,3 ETP	-20.7%	9,2 ETP	+10.8%	8,3 ETP	+9.2%	7,6 ETP	+18.7%	6,4 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 500 k€ and 1 M€

See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

2 active · 24 ended

Active mandates

LA FINANCIERE DE WAHA

Director · 0550.640.393

Represented by Roland Colette

Active

PHARMA BIEN-ÊTRE

Managing director · 0776.600.905

Represented by Tilman MIKAEL

Active

Ended mandates

LA FINANCIERE DE WAHA

Director · since 01 décembre 2021 · 0550.640.393

Represented by Colette ROLAND

Ended

PHARMA BIEN-ÊTRE

Managing director · since 01 décembre 2021 · 0776.600.905

Represented by Tilman MIKAEL

Ended

Invest Nature SARL

Director · since 17 décembre 2020

Represented by Mikael Tilman

Ended

Noé Nature

Managing director · since 24 novembre 2015 · 0837.906.586

Represented by Pierre-Hadi SAAD

Ended

Full financial information

Source · NBB

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	02/07/2026	18/07/2025	02/07/2024	11/07/2023	14/06/2022	30/06/2021
General meeting	29/06/2026	30/06/2025	12/06/2024	14/06/2023	08/06/2022	30/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 20 filings

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	29/06/2026	02/07/2026	French	PDF
Abridged model	31/12/2024	30/06/2025	18/07/2025	French	PDF
Abridged model	31/12/2023	12/06/2024	02/07/2024	French	PDF
Abridged model	31/12/2022	14/06/2023	11/07/2023	French	PDF
Abridged model	31/12/2021	08/06/2022	14/06/2022	French	PDF
Abridged model	31/12/2020	30/06/2021	30/06/2021	French	PDF
Abridged model	31/12/2019	07/09/2020	07/11/2020	French	PDF
Abridged model	31/12/2018	28/05/2019	30/08/2019	French	PDF
Abridged model	31/12/2017	22/05/2018	18/08/2018	French	PDF
Abridged model	31/12/2016	23/05/2017	20/08/2017	French	PDF
Abridged model	31/12/2015	24/05/2016	28/08/2016	French	PDF
Abridged model	31/12/2014	26/05/2015	27/08/2015	French	PDF
Abridged model	31/12/2013	26/05/2014	26/08/2014	French	PDF
Abridged model	31/12/2012	25/05/2013	26/08/2013	French	PDF
Abridged model	31/12/2011	25/05/2012	23/08/2012	French	PDF
Abridged model	31/12/2010	25/05/2011	26/08/2011	French	PDF
Abridged model	31/12/2009	25/05/2010	24/08/2010	French	PDF
Abridged model	31/12/2008	25/05/2009	27/08/2009	French	PDF
Abridged model	31/12/2007	26/05/2008	29/08/2008	French	PDF
Abridged model	31/12/2006	25/05/2007	31/08/2007	French	PDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 500 k€ and 1 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

2 active · 24 ended

Active mandates

LA FINANCIERE DE WAHA

Director · 0550.640.393

Represented by Roland Colette

Active

PHARMA BIEN-ÊTRE

Managing director · 0776.600.905

Represented by Tilman MIKAEL

Active

Ended mandates

LA FINANCIERE DE WAHA

Director · since 01 décembre 2021 · 0550.640.393

Represented by Colette ROLAND

Ended

PHARMA BIEN-ÊTRE

Managing director · since 01 décembre 2021 · 0776.600.905

Represented by Tilman MIKAEL

Ended

Invest Nature SARL

Director · since 17 décembre 2020

Represented by Mikael Tilman

Ended

Noé Nature

Managing director · since 24 novembre 2015 · 0837.906.586

Represented by Pierre-Hadi SAAD

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Mandates28/02/2022
STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - OBJET - DEMISSIONS, NOMINATIONS - ASSEMBLEE GENERALE
PDF
Mandates29/01/2021
DEMISSIONS, NOMINATIONS
PDF
Mandates16/12/2015
DEMISSIONS, NOMINATIONS
PDF
Mandates15/09/2015
DEMISSIONS, NOMINATIONS
PDF
Mandates22/06/2009
DEMISSIONS, NOMINATIONS
PDF
Capital / shares15/03/2004
ASSEMBLEE GENERALE - CAPITAL, ACTIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
PDF
Mandates24/06/2003
DEMISSIONS, NOMINATIONS
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

2025
Annual accounts 2025132,6 k €↑
2024
Annual accounts 2024100,3 k €↑
2023
Annual accounts 202351,1 k €↑
2022
Annual accounts 20226 k €↓
2021
Annual accounts 202110,8 k €↓
2019
Annual accounts 201992,3 k €↑
2018
Annual accounts 201857,8 k €↓
2017
Annual accounts 201791,8 k €↓
2016
Annual accounts 2016109,1 k €↑
2015
Annual accounts 201519,3 k €↑
2014
Annual accounts 2014-10,7 k €↓
2013
Annual accounts 201315 k €↑
2012
Annual accounts 20123,1 k €↑
2011
Annual accounts 2011-12,7 k €↑
2010
Annual accounts 2010-48,4 k €↓
2009
Annual accounts 2009-5,8 k €↑
2008
Annual accounts 2008-8,1 k €↓
2007
Annual accounts 20073,4 k €↓
2006
Annual accounts 20064,9 k €
15/07/1996
IncorporationPublic limited company

PHARMACIE TILMAN

Overview

Identity

Financials

Valuation

Indicative valuation

Board of directors

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline